| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $53.9M | -73.1% |
| R&D Expense | $135.6M | +64.7% |
| SG&A Expense | $49.9M | +7.7% |
| Operating Income | -$131.6M | -282.8% |
| Pre-tax Income | -$125.6M | -274.6% |
| Income Tax | -$8.7M | -275.0% |
| Net Income | -$116.9M | -274.6% |
| EPS (Basic) | -$2.47 | -263.6% |
| EPS (Diluted) | -$2.47 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $710.4M | +22.7% |
| Current Assets | $719.1M | +23.0% |
| Total Assets | $758.0M | +24.4% |
| Current Liabilities | $50.1M | +49.9% |
| Total Liabilities | $136.0M | -5.1% |
| Stockholders' Equity | $622.0M | +33.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$108.8M | -217.5% |
| Investing Cash Flow | -$464K | +19.3% |
| Financing Cash Flow | $241.5M | +26.9% |
| -279.0% |